Portage Biotech Inc. (PRTG)
NASDAQ: PRTG · Real-Time Price · USD
5.43
+0.01 (0.18%)
Aug 4, 2025, 11:41 AM - Market open

HashiCorp Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for HashiCorp.

Price Target: $0.00 (0.00%)
Analyst Consensus: n/a
TargetLowAverageMedianHigh
Pricen/an/an/an/a
Changen/an/an/an/a

Analyst Ratings

There are currently no analyst ratings available for HashiCorp.

Recommendation Trends

RatingAug '23Sep '23Oct '23Nov '23Dec '23Jan '24
Strong Buy111110
Buy222220
Hold000000
Sell000000
Strong Sell000000
Total333330

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Downgrades
n/a
HoldDowngradesn/an/aJan 8, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$180$120
Strong BuyMaintains$180$120+2,109.94%Nov 29, 2023
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
$220
BuyReiterates$220+3,951.57%Sep 7, 2023
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
$220
BuyReiterates$220+3,951.57%Aug 31, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$420$180
Strong BuyMaintains$420$180+3,214.92%Aug 2, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.53
from -5.72
EPS Next Year
n/a
from -0.53
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingMar 31, 2021Mar 31, 2022Mar 31, 2023Mar 31, 2024Mar 31, 2025Mar 31, 2026
Revenue
------
Revenue Growth
------
EPS
-27.00-25.83-129.80-77.90-5.72-0.53
EPS Growth
------
Forward PE
------
No. Analysts
-----3
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue2026
Highn/a
Avgn/a
Lown/a

Revenue Growth

Revenue Growth2026
High-
Avg-
Low-

EPS Forecast

EPS2026
High-0.55
Avg-0.53
Low-0.51

EPS Growth

EPS Growth2026
High-
Avg-
Low-
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.